在瘤治疗中,向蛋白质溶解的嵌合体 (PROTACs) 传递系统的进展
Lianlian Fan1, Weifang Tong2, Anhui Wei3
1Department of Pharmacy, China-Japan Union Hospital of Jilin University, Changchun 130033, China.
International journal of biological macromolecules
|July 6, 2024
概括
针对蛋白质分解的嵌合体 (PROTACs) 提供了一种新的方法来降解引起疾病的蛋白质. 增强PROTAC传递系统对于克服挑战和推进癌症治疗策略至关重要.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 针对蛋白质溶解的嵌合体 (PROTACs) 利用细胞机械来向蛋白质降解,这代表了癌症治疗的有前途战略.
- 目前PROTACs的局限性包括溶解性差,细胞透性低,以及非目标效应,阻碍临床前进展.
- 有效的输送系统对于克服这些挑战和实现精确瘤向至关重要.
研究的目的:
- 系统地审查 PROTAC 交付系统的设计原则.
- 总结最近在各种PROTAC交付策略中的进展.
- 为开发多功能 PROTAC 交付系统提出建设性的方法.
主要方法:
- 文献综述,重点关注 PROTAC 交付系统.
- 分析设计原则和最近的进展.
- 综合多功能交付系统的战略.
主要成果:
- 详细概述各种PROTAC交付系统设计的详细概述.
- 确定关键挑战及其相应的解决方案.
- 开发先进的多功能交付系统的框架.
结论:
- 多功能传递系统对于PROTACs在癌症治疗中的成功至关重要.
- 这些系统的进一步开发将提高PROTAC的有效性和安全性.
- 本综述提供了加快PROTAC药物开发的见解.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509


